Abnormal lipid metabolism, renal lipid accumulation and lipotoxicity are associated with the pathological features of glomerulopathy. However, the mechanisms by which lipid accumulation leads to the development or progression of this disease have not been fully elucidated. In this work, we have identified a role for the rate-limiting enzyme in lipolysis, adipose triglyceride lipase (ATGL; also called patatin-like phospholipase domaincontaining protein 2), in renal lipid metabolism and kidney disease. ATGL-deficient (Atgl(À/À)) mice displayed albuminuria, accompanied by ectopic deposition of fat in the kidney. Magnetic resonance imaging demonstrated that the contrast agent gadopentetic acid was retained in kidney tissue, suggesting defects in the glomerular filtration barrier. Furthermore, transmission electron microscopy revealed lipid deposits in the podocyte, along with foot process fusion and morphological changes suggestive of apoptosis. Indeed, shRNA-mediated depletion of ATGL promoted podocyte apoptosis, accompanied by increased levels of intracellular reactive oxygen species (ROS) and F-actin fibre redistribution. These effects could be partially reversed by treatment with the antioxidant Nacetylcysteine. These data suggest that ATGL deficiency induces renal lipid accumulation, proteinuria and glomerular filtration barrier dysfunction and implicate increased intracellular ROS levels in inducing podocyte F-actin rearrangement, foot process fusion and apoptosis that underlie these pathological features.
Introduction
There is growing evidence that abnormal lipid metabolism and renal lipid accumulation play a role in chronic kidney disease, such as obesity-related chronic kidney disease and diabetic nephropathy [1] [2] [3] [4] . Abnormal renal lipid content has also been described in a number of animal models with renal injury and has been successfully manipulated using pharmacological or genetic strategies [5] .
Overload of triglyceride (TG) and its metabolic product, free fatty acid (FFA), in plasma can result in endothelial dysfunction and vascular damage by direct adhesion and inflammation [6] . Fatty acids can be converted into cytotoxic lipid intermediates, such as diacylglycerol, ceramides and fatty acyl-CoAs [7] [8] [9] . Moreover, excess extracellular FFAs imported into non-adipose cells are accumulated as ectopic lipid and shunted into non-oxidative pathways that disrupt normal cellular signalling, leading to cell dysfunction and apoptosis [10] . In kidney disease, studies have found that the specific cell types affected by excessive lipid accumulation are proximal tubular cells, podocytes and mesangial cells [2] , and TG accumulated in lipid droplets has been associated with glomerulosclerosis and tubular interstitial injury [11] . However, how these lipid deposits originate and the major molecular mechanisms of lipid-mediated nephropathy remain unknown.
Adipose triglyceride lipase (ATGL) is an important component of the lipolytic process and the rate-limiting enzyme for the initiation of TG catabolism [12] . Haemmerle et al. [13] reported for the first time that TG content in myocytes of ATGL-deficient (Atgl (À/À)) mice, compared with Atgl(+/+) mice, increased by more than 20-fold. A marked disturbance of the cardiac texture and increased fibrosis were also noted. Cardiomyocyte apoptosis was observed in this process. Since then, many studies have examined the relationship between ATGL and cardiac dysfunction [14] [15] [16] . In another vital internal organ, the kidney, > 10-fold accumulation of TG was observed in Atgl(À/À) mice [13] . Whether ATGL plays roles in the regulation of renal lipid metabolism and the development of diabetic nephropathy has not been determined.
In the present study, we first investigated the roles of ATGL in renal lipid metabolism and kidney dysfunction using Atgl(À/À) mice. An ATGL-knockdown podocyte model was also established to explore the possible mechanism. ATGL deletion induced massive albuminuria, accompanied by renal ectopic deposition of fat in mice. ATGL knockdown promoted podocyte apoptosis accompanied by increased intracellular reactive oxygen species (ROS) and redistribution of Factin fibre. These effects could be partially reversed by treatment with the antioxidant N-acetylcysteine (NAC).
Results

ATGL deficiency leads to a lipid metabolism disorder in mice
To determine the impact of ATGL deficiency on lipid metabolism in vivo, we assessed the changes in blood lipid concentration and tissue fat distribution in Atgl(À/À) mice. Polymerase chain reaction (PCR) and western blotting were performed to verify the deficiency of ATGL in Atgl(À/À) mice (Fig. 1A,B) . The body weights of Atgl(À/À) mice were significantly higher than those of Atgl(+/+) mice at as early as 8 weeks of age and progressively increased with age (Fig. 1C) . Serum FFA, TG and total cholesterol (TC) were significantly decreased in Atgl(À/À) mice (*P < 0.05; Fig. 1D ). We further examined the TG contents of the heart, the liver and the kidney. TG accumulation was dramatically increased in all three organs of Atgl(À/À) mice compared with those of the control group (*P < 0.05; Fig. 1E ). These findings indicated that there were disorders in lipid metabolism and distribution in Atgl(À/À) mice, and that ATGL might take part in renal lipid metabolism and chronic kidney disease development.
Atgl(À/À) mice develop proteinuria and lipid droplet accumulation in the kidney
To further clarify the potential pathological role of ATGL deficiency in kidney disease, the renal morphology and function of Atgl(À/À) mice were analysed. As illustrated in Fig. 2A , Atgl(À/À) mice had much smaller kidneys when compared with age-and sex-matched control mice (Fig. 2B; *P < 0.05 vs the Atgl (+/+) mouse group).
Although no significant change in serum creatinine (CR) between the two groups was noted (Fig. 2C) , as an early indication of renal injury, the urine albumin/ creatinine ratio (UACR)ratio was significantly elevated in Atgl(À/À) mice when compared with lean mice ( Fig. 2D ; *P < 0.05 vs the Atgl(+/+) mouse group), and the Atgl(À/À) mice had a much higher CR clearance than Atgl(+/+) mice ( Fig. 2E ; *P < 0.05 vs the Atgl(+/+) mouse group). Otherwise, a decrease in the volume of the capsular space in Atgl(À/À) mouse kidneys could be observed under light microscopy with hematoxylin and eosin staining, while no significant difference was found related to the glomerular volume ( Fig. 2F -H; *P < 0.05 vs the Atgl(+/+) mouse group). Oil red O was used to stain the lipid droplets (Fig. 2I) . As expected, the renal cortex in Atgl(À/À) mice demonstrated marked accumulation of lipid droplets, including the glomeruli; in contrast, there was little lipid accumulation in the glomeruli of Atgl(+/+) mice. These data indicated that ATGL deletion caused significant albuminuria and lipid accumulation in the glomeruli.
ATGL deficiency destroys the integrity of the glomerular filtration barrier
The glomerular filtration barrier plays a crucial role in preventing protein filtration at the glomeruli, and mass proteinuria indicated the dysfunction of the glomerular filtration barrier (Fig. 2D ). We applied magnetic resonance imaging (MRI) to further estimate the integrity of the glomerular filtration barrier in Atgl(À/À) mice. Gadopentetic acid (GdDTPA) is excreted by glomerular filtration, and it has been reported that the plasma clearance of GdDTPA is an effective method to estimate glomerular filtration rate (GFR) [17] . Figure 3A ,B shows inversion-recovery T1 maps in which T1 relaxation time was inversely proportional to the content of GdDTPA retained in the kidney tissue. Quantitative time course analysis of the T1 relaxation time indicated that there was a dramatic decrease of T1 relaxation time in the Atgl(À/À) group from 1 h to 17 h post-injection ( Fig. 3B ; *P < 0.05 vs the Atgl(+/+) group), suggesting an increased concentration of GdDTPA retained in the kidney tissue and a predictable decreased GFR in Atgl(À/À) mice.
To provide insight into the mechanism of the glomerular filtration barrier dysfunction in Atgl(À/À) mice, the ultrastructure of the glomerular filtration barrier was further examined via transmission electron microscopy (TEM; Fig. 3C ). Plenty of lipid droplets deposited in podocytes (white triangles in Fig. 3Cc,d ) were observed in Atgl(À/À) mice. In addition, ATGL deficiency induced foot process fusion (the enlarged areas in Fig. 3Cc,d ) and cavitation of the mitochondrial matrix compared with the Atgl(+/+) mice (black triangles in Fig. 3Ca,b,d ). Some glomerular cells displayed early morphological characteristics of cell death, including chromatin condensation and size shrinkage, associated with severely damaged cytoplasmic structures (white ovals in Fig. 3Cc ). To quantify the degree of foot process fusion, the number of junctions per micrometer glomerular basement membrane ) and TG contents in the heart, liver and kidney (E) were measured. The averages were expressed as the means AE SEM (n = 8 mice/group) and the experiments were repeated three times. Significant differences between groups were assessed by t test. *P < 0.05 vs Atgl(+/+) mice.
(GBM) was determined (Fig. 3D ). The Atgl(+/+) mice have much more junctions per lm GBM than the Atgl (À/À) mice (*P < 0.05 vs the Atgl(+/+) mouse group), suggesting foot process effacement in Atgl(À/À) mice. Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining revealed increased cellular apoptosis in the glomeruli of Atgl(À/À) mice ( Fig. 3E , F; *P < 0.05 vs the Atgl(+/+) group). Figure 3G shows that some TUNEL-positive glomerular cells (dark brown nucleus indicated by red arrows) were colocalized with nephrin (pink cytoplasm indicated by green arrows) as a marker for podocytes.
In all, the evidence of proteinuria, foot process fusion and apoptosis of glomerular cells proved that the integrity of the glomerular filtration barrier of the Atgl(-/-) mice was disrupted.
ATGL knockdown results in F-actin rearrangement and apoptosis in podocytes
Our previous study suggests that podocytes may play a key role in the dysfunction of the glomerular filtration barrier caused by ATGL deficiency. To more directly illuminate the effect of ATGL on podocytes, we established ATGL-knockdown podocytes using shRNA lentivirus transfection. Western blotting was performed to confirm the suppressive effect of ATGL-shRNA treatment (Fig. 4A ). Considering that extensive effacement of the foot processes was observed in the podocytes of Atgl(À/À) mice (the enlarged areas in Fig. 3Cc,d ) and that actin filaments are the major components of the cytoskeleton for maintaining the integrity of foot processes in podocytes, we observed the changes of F-actin The kidneys of Atgl(À/À) mice were smaller than those of the control grou(C-E) Blood and 24 h urine samples were collected in both groups and the concentrations of serum CR, urinary albumin and urinary CR were measured. No significant changes in serum CR were detected in the two groups (C). UACR and CR clearance were calculated to evaluate kidney damage at an early stage (D,E). UACR of the Atgl(À/À) mouse group was significantly higher (D), while the CR clearance was lower than that of the control group (E). (F-H) Hematoxylin and eosin staining showed that the renal capsules of Atgl(À/À) mice were much smaller than those of Atgl(+/+) mice, but the volumes of the glomeruli in the two groups remained unchanged. The volumes of renal capsules were calculated according to the volume of renal corpuscles minus the volume of glomeruli. (I) Oil red O staining revealed lipid accumulation in the renal cortex, including the glomeruli of Atgl(À/À) mice. The averages of serum CR and CR clearance were expressed as the means AE SEM, and significant differences between groups were assessed by the t test. The averages of kidney weight, UACR and the volumes of renal capsules or glomeruli were expressed as the median and interquartile range, and the significant differences between groups were assessed by the Kruskal-Wallis H test. n = 8 mice/group and the experiments were repeated three times. *P < 0.05 vs Atgl(+/+) mice. The averages of T1 relaxation time, junctions per micrometer GBM and apoptotic cells were expressed as the means AE SEM, and significant differences between groups were assessed by t test. n = 8 mice/group and the experiments were repeated three times. *P < 0.05 vs Atgl(+/+) mice. The averages of annexin V-Cy3/SYTOX or TUNEL positive cells were expressed as the means AE SEM, and significant differences between groups were assessed by t test. n = 6/ group and the experiments were repeated three times. *P < 0.05 vs the scrambled-shRNA group.
1075
The FEBS Journal 284 (2017) 1070-1081 ª 2017 Federation of European Biochemical Societies distribution in ATGL-shRNA-treated podocytes. Phalloidin staining suggested that ATGL knockdown induced stress fibres reorganized from the perinuclear area towards the periphery of the cells (Fig. 4B) . We further examined the effect of ATGL knockdown on podocyte apoptosis or necrosis. By double staining living cells with annexin V-Cy3 (red) and SYTOX dye (green), we could distinguish early apoptosis (annexin V+/SYTOX-), late apoptosis (annexin V+/SYTOX+) or necrosis (annexin V-/SYTOX+) in podocytes (Fig. 4C) . Apoptosis (annexin V+) was significantly increased in ATGL-shRNA-treated podocytes compared with scrambled shRNA treatment. Interestingly, even though necrosis seems increased in ATGL-shRNA-treated podocytes in Fig. 4C , no statistical difference was observed (annexin V-/SYTOX+) between the two groups ( Fig. 4D ; *P < 0.05 vs scrambled-shRNA group), suggesting that apoptosis, but not necrosis, was involved in ATGL-knockdown-induced podocyte death.
The increased apoptosis was further demonstrated by TUNEL staining, which showed increased apoptosis in ATGL-knockdown podocytes ( Fig. 4E ,F; *P < 0.05 vs the scrambled-shRNA group). These findings identify ATGL as a modulator of podocyte F-actin distribution and apoptosis, but not necrosis.
Involvement of ROS in ATGL-related podocyte apoptosis
The mechanisms implicated in ATGL-knockoutinduced podocyte apoptosis are still under investigation. Considering that mitochondria were impaired in the podocytes of Atgl(À/À) mice (black triangles in Fig. 3Cd) , and that the mitochondrial injury-induced increase in ROS participates in the ATGL-induced adipocyte apoptosis [15] , we asked whether ROS played a role in ATGL-knockout-induced podocyte apoptosis. Intracellular ROS production was assessed using a 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence assay, and the results demonstrated that ROS in the kidney tissue of Atgl(À/À) mice were significantly elevated ( Fig. 5A ; *P < 0.05 vs the Atgl(+/+) group). The intracellular ROS production was significantly elevated in ATGL-shRNA podocytes compared with the scrambled-shRNA group, and the increased ROS level could be reduced after treatment with NAC, an active oxygen scavenger (Fig. 5B) . Accordingly, ROS scavenging alleviated the rearrangement of Factin (Fig. 5C ) and improved podocyte apoptosis detected by annexin V-Cy3 ( Fig. 5D ,E; *P < 0.05 vs the scrambled-shRNA group, # P < 0.05 vs the ATGLshRNA group) or TUNEL staining ( Fig. 5F ,G; *P < 0.05 vs the scrambled-shRNA group, # P < 0.05 vs the ATGL-shRNA group). These findings indicated that ROS accumulation may be an important mediator of the ATGL knockout-induced F-actin distribution and apoptosis in podocytes.
Discussion
Glomerulopathy is characterized by proteinuria, glomerulomegaly or atrophy, progressive glomerulosclerosis and renal functional decline, and many factors are to blame for it [18] . Over the decades, the therapeutic interventions of glomerulopathy have been limited, partly because of limited understanding of the pathogenic mechanisms. Lipid metabolism disorder is one of the factors that lead to glomerulopathy [19] . Obesity patients with glomerulopathy present an altered serum lipid profile characterized by elevated TG-rich lipoproteins beginning in the earliest stages of microalbuminuria [20] . In diabetic patients, intraglomerular lipid deposits were first described by Kimmelstiel and Wilson in 1936 and were subsequently observed by other researchers [21, 22] . It is widely recognized that ectopic deposition of lipids causes harm to target cells and organs; ectopic lipid accumulation in the kidney promotes maladaptive responses of renal cells to the mechanical forces of hyperfiltration, leading to podocyte depletion, proteinuria, focal segmental glomerulosclerosis and interstitial fibrosis, but the reasons why lipid deposits accumulate in the kidney during glomerulopathy are still unknown.
Adipose triglyceride lipase predominantly performs the initial step in TG hydrolysis and, thus, seems to play a pivotal role in lipid catabolism. Mice lacking the ATGL gene generate ectopic lipid deposition into internal organs, such as the heart, liver and kidney, and develop severe symptoms, such as inadequate cardiac and hepatic function. In this study, we first demonstrated that ATGL deletion led to severe damage of the glomerular filtration barrier and proteinuria in Atgl(À/À) mice, which has been attributed to podocyte injury due to foot process fusion and apoptosis. As the mitochondrion is the major organelle maintaining ROS balance, mitochondrial loss results in elevation of ROS, which can induce cell apoptosis by activating downstream effector caspases. In our study, the morphological changes of mitochondria in podocytes under TEM (black arrows in Fig. 3Ca,c,d ) implied the possible role of mitochondria in ATGLdeficiency-induced podocyte apoptosis. An in vitro experiment using ATGL-shRNA podocytes further suggested that the intracellular accumulation of ROS may be the key mediator involved in F-actin distribution (related to foot process fusion) and apoptosis.
These results demonstrated that the suppressed lipid catabolism attributed to ATGL deficiency may bring about renal ectopic deposition of lipids in glomerulopathy, but further study is needed to confirm this hypothesis.
Lipotoxicity has been associated with the development of nephropathy in patients with diabetes or metabolic syndrome. Over the years, the mechanisms involved in lipotoxicity-related nephropathy have been poorly understood; one of the main causes for this The averages of annexin V-Cy3/SYTOX or TUNEL positive cells were expressed as the means AE SEM, and significant differences between groups were assessed by t test. n = 6/group and the experiments were repeated three times. *P < 0.05 vs scrambled-shRNA, # P < 0.05 vs ATGL-shRNA podocytes.
lack of understanding has been the lack of an appropriate animal model that perfectly simulates the pathological changes of lipotoxicity-induced nephropathy. Atgl(À/À) mice have some notable advantages in simulating the pathological changes seen in human disease: first, excess TG accumulation and ROS overload in the kidney imply severe lipotoxicity; and second, mature Atgl(À/À) mice (9-10 weeks) developed stable, significant albuminuria and glomerular filtration barrier dysfunction, which resembled the early pathological changes of glomerulopathy. However, this model showed some limitations because although proteinuria persisted in Atgl(À/À) mice (9-10 weeks), the plasma urea and CR levels remained the same. It is worth mentioning that, although the retained GdDTPA strongly hints at decreased GFR, no significant change in serum CR between the two groups was noted (Fig. 2C) , which suggests that the MRI may be more sensitive than the serum CR concentration for estimating GFR. Under TEM, podocyte injuries, such as mitochondrion cavitation, chromatin condensation and severely damaged cytoplasmic structures, could be observed (Fig. 3C ), but typical apoptotic podocytes were rarely observed. However, in an in vitro culture of ATGL-shRNA-treated podocytes, ATGL knockdown induced significant cell apoptosis. All of these findings suggest that the nephropathy of Atgl(À/À) mice (9-10 weeks) is closer to the early stage of glomerulopathy and that extending the use of Atgl (À/À) mice over time may help in studies of nephropathy in an advanced stage of the disease. However, TG accumulation in Atgl(À/À) mice is not kidney specific [13] , and these mice have a limited life span due to their fragile cardiac function, which may affect the progress of pathological changes in the kidney. Therefore, a mouse model of kidney disease with specific ATGL knockout could help to solve this problem. Taken together, our findings indicate that ATGL plays important roles in maintaining normal lipid metabolism of the kidney and renal function. ATGL deletion in mice leads to ectopic deposition of fat in the kidney, and induces dysfunction of the glomerular filtration barrier and albuminuria. In the podocytes, ATGL inhibition promotes cell apoptosis accompanied by redistribution of F-actin fibres, and these effects may result from mitochondrial injury-induced ROS overload.
Materials and methods
Ethics
All experimental procedures were approved by the Animal Care Centre of the Third Military Medical University, and complied with the Care and Use of Laboratory Animals protocol published by the US National Institutes of Health.
Mice
Inbred male Atgl(À/À) Pnpla2, 0610039C21Rik, Gene ID: 66853) and age-matched male Atgl(+/+) littermate mice (C57BL/6) were produced by mating Atgl(+/À) inbred male and female breeders purchased from The Jackson Laboratory (Bar Harbor, Maine, ME, USA; cat. no. 019003). All mice were housed under standard conditions with normal food and water. To screen Atgl(À/À) and Atgl(+/+) mice, PCR and agarose gel electrophoresis were formed according to standard procedures. Mice were weighed every week from 4 weeks of age, and a growth curve was drawn. All mice used in experiments were 9-10 weeks old and weighed~20 g.
Biochemical tests of urine, blood and tissue samples
For measuring the urine albumin and CR, Individual mice were housed in metabolic cages, and 24 h urine volume (V 24 h ) was monitored, and the albumin concentration (Shanghai Biosun Sci & Tech Co. Ltd, Shanghai, China; cat. no. 1011) and CR (Sigma-Aldrich, St Louis, MO, USA, cat. no. MAK080) were determined using commercial assay kits. Blood samples were collected by retro-orbital bleeding and clotted for 12 h at 4°C before centrifugation at 3000 g for 10 min. The sera were collected, and TC (Sigma-Aldrich, cat. no. MAK043), TG (Sigma-Aldrich, cat. no. TR0100), FFA (Sigma-Aldrich, cat. no. MAK044) and CR (Sigma-Aldrich, cat. no. MAK080) were tested according to the manufacturer's protocols. The creatinine clearance rate (C CR ) was estimated using the equation C CR (lLÁmin À1 ) = [100 9 V 24 h (mL) 9 urine CR (mgÁdL
1440), where V 24 h is 24 h urine volume. For the determination of tissue TG content, fresh kidney, liver and heart tissues were excised and washed in PBS, and the total lipids were extracted by the method of Folch [23] . The TG content was measured with a commercial kit (Applygen, Beijing, China; cat. no. E1003-2).
Histology and ultrastructural pathology
The kidneys harvested from each group were photographed and weighed, fixed in 4% buffered formaldehyde overnight, dehydrated in a sucrose gradient and embedded in paraffin. Tissue sections (6-8 lm) were cut and stained with hematoxylin and eosin. Six serial sections from each mouse were used to measure the glomerular volume: 12 glomeruli and capsular spaces were randomly selected from each section, and the volume of the glomeruli and capsular spaces was calculated as previously described [24] . For oil red O staining, kidney tissues were fixed in 4% buffered formaldehyde overnight, dehydrated in a sucrose gradient, and embedded in OCT, sectioned on a cryostat, and stained with oil red O (Sigma-Aldrich; cat. no. MAK194). For TEM observations, renal cortices were cut into 1 9 1 9 1 mm pieces, fixed in glutaraldehyde, dehydrated, sliced on a vibrating blade microtome, recut on a microtome and stained with uranyl acetate and lead citrate overnight. The sections were examined using a transmission electron microscope (TECNAL-12, Philips Electron Optics, Eindhoven, Netherlands). The degree of foot process fusion was determined by measuring the number of junctions per 1 lm length of GBM as described previously [25] . At least 10 glomeruli per kidney were analysed.
Magnetic resonance imaging
Nine-to 10-weeks-old male Atgl(À/À) and Atgl(+/+) mice (n = 8,~20 g) were used. Atgl(À/À) mice were imaged before (0 h)and at 1, 17 and 40 h after intravenous tail injection of GdDTPA (0.2 mmol gadoliniumÁkg À1 , GE Healthcare, Cork, Ireland). Age-matched Atgl(+/+) mice injected with GdDTPA were imaged at the same time points and served as controls. MRI was performed on a 7.0 T Bruker (Billerica, MA, USA) horizontal bore scanner equipped with a home-built radio frequency transmitter and receiver with 2 9 2 cm elliptical surface coil using PAR-AVISION 6.0 software (Bruker). T1 maps were obtained.
Podocyte culture and treatment
Conditioned immortalized murine podocytes were obtained from the Cell Resource Centre, Peking Union Medical College (the headquarters of the National Infrastructure of Cell Line Resource, NSTI). The cell line was confirmed to be free of mycoplasma contamination by PCR and culture. Its species origin was confirmed with PCR. The identity of the cell line was authenticated with short tandem repeat profiling (CODIS, the FBI Laboratory, Quantico, VA, USA). All of the results can be viewed on the website http://cellresource.cn/. Podocytes were cultured as previously described [26] . Briefly, growth medium consisting of RPMI 1640 containing 10% fetal bovine serum supplemented with interferon-c (10 UÁmL À1 ) supported cell proliferation at 33°C. After switching the cells to a medium without interferon (IFN)-c at 37°C, the cells exited the cell cycle and started differentiation. In some experiments, to inhibit ROS generation, medium was pretreated with NAC (5 mmolÁL À1 ). All cell experiments were performed on day 14 after the thermal shift and were performed in triplicate.
Lentivirus vector-mediated ATGL silencing
The ATGL-shRNA vector was constructed in our laboratory [27] . A scrambled-shRNA-expressing virus was used as a control [28] . Lentivirus production was accomplished as previously described [29] . Podocytes were treated with ATGLshRNA lentivirus before differentiation. To determine the optimum level of ATGL expression, an immunoblotting technique was adopted to measure the multiplicity of infection and the duration of infection for each lentivirus.
Fluorescence staining of F-actin
Podocytes were plated on laminin-coated glass coverslips and were cultured as described above. To observe the F-actin cytoskeleton, the cells were washed thrice with PBS, fixed in 4% paraformaldehyde for 15 min, and washed thrice again with PBS, followed by permeabilization with 0.1% Triton X-100 (Beijing Dingguo Changsheng Biotechnology Co. Ltd, Beijing, China; cat. no. AR-0341) for 15 min. Alexa Fluor 633 phalloidin (Molecular Probes, Eugene, OR, USA; cat. no. A22284) was used to stain F-actin. Cells were then observed using a confocal laser scanning microscope (TCS-NT; Leica, Wetzlar, Germany). The experiment was repeated thrice.
Western blot analysis
Kidney tissue samples and podocytes were homogenized in a tissue protein extraction reagent (T-PER, Thermo Scientific, Shanghai, China) and radio immune precipitation assay (RIPA) buffer (Sigma-Aldrich), respectively. Just prior to use, two cocktails (a protease inhibitor cocktail with phenylmethylsulfonyl fluoride and a phosphatase inhibitor cocktail) were added to the buffer. To remove insoluble protein, the lysate was centrifuged at 16 000 g for 15 min at 4°C. SDS/PAGE on 8-12% gradient gels was performed after equal quantities of proteins, as measured using a bicinchoninic acid-based assay (Pierce, Rockford, IL, USA), were loaded for each sample. Proteins were separated and transferred to polyvinylidene difluoride membranes (Millipore, Chengdu, China), which were then blocked with 10% skimmed milk and incubated overnight at 4°C with the corresponding primary antibodies. After incubation with a biotinylated secondary antibody, specific protein bands were detected using avidin biotinylated horseradish peroxidase in conjunction with an enhanced chemiluminescence detection kit (GE Healthcare) and the ChemiDocXRS system (BioRad Laboratories, Inc., Hercules, CA, USA). The intensity of the band signals was quantified using Quantity One quantitative software (Bio-Rad Laboratories). This complete procedure was repeated thrice. The antibodies used in this experiment were as follows: rabbit monoclonal anti-ATGL (Thermo Fisher Scientific, Waltham, MA, USA; cat. no. MA5-14990) and goat monoclonal anti-Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; LifeSpan BioSciences, Seattle, WA, USA; cat. no. LS-C36500-100).
Apoptosis and reactive oxygen species assay
An Annexin V-Cy3Apoptosis Detection Kit Plus (Biovision, Palo Alto, CA, USA; cat. no. K202-100) and an in Situ Cell Death Detection Kit (Roche, Shanghai, China; cat. no. 11684817910) were used for the apoptosis assay. TUNEL-positive glomerular cells were co-localized with nephrin as a marker for podocytes, in which rabbit antinephrin primary antibody (1 lgÁmL
À1
, CAT 2265; ProSci Inc., Poway, CA, USA), biotinylated second antibody (Maixin Biotech Co., Ltd, Fuzhou, China) and AEC Kit (AEC-0037, Maixin Biotech. Co.) were used. Cells were observed using an Olympus microscope (Olympus Optical Co., Ltd, Tokyo, Japan). Fifteen representative images of each group were randomly chosen, and the apoptotic index was calculated: (apoptotic nuclei/number of total nuclei) 9 100 using IMAGE-PRO PLUS 5.0 software (Media Cybernetics, Rockville, MD, USA).
Reactive oxygen species generation in the kidney tissue was measured as described [30] with minor modifications. Freshly frozen kidney homogenate (1 mg) was incubated in 1 mL of buffer A containing 10 lM DCFH-DA (SigmaAldrich; cat. no. D6883). After 30 min incubation at room temperature, the changes in fluorescence intensity were monitored using Varioskan Flash (Thermo Fisher Scientific). For fluorescence microscopic determination of ROS generation from podocytes, cells were incubated in PBS containing DCFH-DA (10 lM) in the dark at 37°C for 30 min and washed with PBS three times. The fluorescence was observed with a fluorescence microscope (Leica Microsystems, Wetzlar, Germany). The experiments were repeated three times.
Statistical analysis
All experiments in this study were performed in triplicate, and the averages were expressed as the mean AE SEM or median and interquartile range. Significant differences between groups were assessed by Student's t test or the Kruskal-Wallis H test as required. In all comparisons, Pvalues < 0.05 were considered statistically significant. Statistical analyses were performed with the software programs SPSS Statistics, version 19 (IBM Corp., Armonk, NY, USA) and PASS 11 (NCSS Inc., Williamsport, PA, USA).
